The cytokine, interleukin 12 (IL-12), stimulates both natural killer cells and T cells to proliferate and to secrete interferon 3, (IFN-3~). The T cell proliferative response to IL-12 must be induced and is evident after T cell receptor-mediated stimulation. As reported here, tolerant CD4 § T cells and clones, that are anergic for IL-2 production, are also anergic for induction of the proliferative response to IL-12. Murine T helper I clones tolerized in vitro, as well as anergic CD4 + T cells isolated from mice tolerized to the Mls-P antigen (Ag) in vivo, demonstrated defective induction of proliferation to IL-12 upon restimulation with Ag. IL-12-enhanced production of IFN-'y was observed in both control and anergic cells after Ag/antigen-presenting cell (APC) activation, although total IFN-y secretion by anergic cells was less than that produced by control cells, even in the presence of IL-12. These data indicate that T cell clonal anergy results in profound inhibition of proliferative responses, since the autocrine growth factor, IL-2, is not produced, and the APC-derived cytokine, IL-12, is not an effective stimulus for anergic T cell proliferation.
T cell anergy can be induced in Thl clones in vitro by ligation of the TCR in the absence of costimulatory signals (1) (2) (3) , and can also be induced in vivo in mature CD4 + T cells by the injection of superantigens (4) (5) (6) . Such anergy is characterized by a block in IL-2 production, resulting in proliferative nonresponsiveness to Ag (7) . In addition, anergic Thl and Th0 clones are nonresponsive for the induction of proliferation to IL-4 (8, 9) . These data suggest that the focus of functional anergy is to prevent expansion of tolerant Ag-reactive clones upon Ag challenge. It was recently determined that the cytokine, IL-12, produced by macrophages and B ceils (10) , stimulates the proliferation of T cells after TCR-induced activation and induces the production of IFN-3~ (11) (12) (13) . Furthermore, IL-12 plays an important role in directing a predominantly Thl-like response in T cell populations (14, 15) . The work reported here demonstrates that anergic T cells are impaired for induction of proliferation to IL-12, as they are for induction of proliferation to IL-4 (8, 9) and for induction of IL-2 synthesis (1-3, 7).
Materials and Methods
Mice. Female B10.BR/SgSnJ or B10.A/SgSnJ mice were pur-T Cell Anergy In Viva Adult TCR Vfl8.1 transgenic mice were injected intravenously with 1.5 x 107 Mls-P-positive T-depleted CBA/J spleen cells to induce anergy, or were injected with PBS for control mice. On day 14 after injection, the inguinal, popliteal, axillary, brachial, and cervical LN were removed and CD4 + T cells were purified and restimulated (5 x 104/well) for 84 h with Mls-P-positive stimulator cells (5 x 10S/well), as described (6) , in the presence or absence of routine rlL-12.
IFN-7 Production. IFN-3~ concentrations were determined using an ELISA assay that employed the R4-6A2 mAb (20) for capture, and a polyclonal rabbit anti-mouse IFN-3, serum for detection with horseradish peroxidase-coupled donkey anti-rabbit IgG (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) and the substrate, 2,2'-azino-di[3-ethyl-benzthiazoline sufonate(6)] (Kirkegaard & Perry Laboratories, Inc., Gaithersburg, MD). Dilutions of culture supernatants were assayed in the linear portion of the dose-response curve. OD405 values were converted to units based on a standard IFN-3' preparation obtained from GIBCO BILL (Gaithersburg, MD).
Results and Discussion
Induction of IL-12 Responsiveness for Proliferation. The CD4 § Thl clone, A.E7, was cultured with APC and suboptimal concentrations of specific Ag, in the presence or absence of exogenous murine rlL-12 ( Fig. 1) . A low level of proliferation in response to IL-12 was noted in the absence of Ag, but addition of Ag to the culture resulted in greatly increased proliferation to IL-12, even at Ag concentrations that alone stimulated little proliferation. Optimal responses were found with IL-12 at 1-3 ng/ml, and were always synergistic with Ag stimulation. Similar results were found with two additional Thl clones ( Fig. 2 A and data not shown). Thus, Ag/APC activation can stimulate the Thl clones used in this study for a proliferative response to IL-12, as has been reported for other T ceUs (11) .
Impaired Induction of lL-12-mediated Proliferation in Anergic Tkl Cells. As previously reported, activation of Thl calls
by immobilized anti-CD3 Ab in the absence of APC results in the induction of anergy, which is characterized by the longlived inability to produce IL-2 or to proliferate to subsequent stimulation by Ag plus competent APC (17, 21) . Thl cells constitutively express IL-2R, and, after induction of anergy, rested anergic cells continue to express IL-2R and to maintain proliferative responses to exogenous IL-2 (1-3). In contrast, the ability to proliferate in response to IL-4 must be induced in Thl cells, and anergic cells are defective for this induction by Ag (8) . Similar to the IL-4 situation, optimal proliferation in response to IL-12 must also be induced in Thl cells. Therefore, to determine whether anergic Thl ceils can be induced by Ag to proliferate to IL-12, the A.E7 or AC24 Thl clones were first precultured with immobilized anti-CD3 Ab to induce anergy, and then were rested before restimuIation with Ag/APC in the presence or absence of murine rlL-12.
As shown in Fig. 2 , proliferative anergy to Ag/APC alone was evident in cells that had been precultured with immobilized anti-CD3 Ab (Fig. 2 , open symbols, 0 ng/ml IL-12).
Proliferation to IL-12 in the absence of Ag was low for both control and anergic cells (Fig. 2, closed symbols) . The striking observation was that the Ag-mediated induction of responsiveness to IL-12 was considerably decreased in anergic vs control cells (Fig. 2, open boxes vs open triangles, respectively), indicating that anergic cells are severely impaired for induction of IL-12 responsiveness. This result was confirmed with three Thl clones and was observed at all Ag concentrations tested (data not shown). Decreased proliferation to IL-12 was apparent both in anergic cells rested for a relatively short time, such as 4-5 d (Fig. 2, A and B) and in those cells rested for 12 d after induction of anergy ( Fig. 2 C) . Decreases ranged from 50-85% when IL-12 was present at maximal concentrations, and anergic cells were 10-1,000-fold less sensitive to IL-12 than control cells. The minimal IL-12-mediated enhancement of proliferation still evident in anergic cells cultured with Ag may reflect a small number of cells in the population that escape anergy induction, or may indicate that anergic cells exhibit a greatly decreased, but not completely abolished response to IL-12. These results thus demonstrate that, in addition to a block in IL-2 production (1-3, 7) and a block in the induction of competency to proliferate to IL-4 (8), long-term anergic Thl cells are also impaired for the TCRmediated induction of IL-12 responsiveness. All three defects result in T cells that are compromised for proliferation, since anergic cells cannot produce IL-2 and cannot respond to growth factors secreted by other cell types.
Role of lL-2 in the Induction of IL-12 Responsiveness. To de-
termine whether the well-documented defect in IL-2 production in anergic cells contributes to the additional defect in IL-12 responsiveness, we first tested whether ongoing IL-2 synthesis was required for proliferation to IL-12 after Ag stimulation. Thus, rested control or anergic A.E7 cells were activated overnight with APC and Ag at the concentrations shown in Fig. 3 A, in the absence oflL-12. APC were then removed, and washed T cells were cultured with IL-12 in the presence or absence of Cyclosporin A (CsA) to inhibit any residual IL-2 production in control cell samples. CsA had little effect on the IL-12-mediated proliferation of Ag-preactivated control or anergic cells, indicating that the anergic cell defect cannot be explained by ongoing IL-2 production in control, but not anergic cells.
However, a requirement for IL-2 during the Ag activation step was still possible. This question was addressed using two approaches. First, control A.E7 cells were activated by Ag/APC in the presence of CsA to block IL-2 synthesis. T cells were then recovered, washed, and cultured with IL-12 alone. As seen in Fig. 3 B, the presence of CsA during the Ag activation step did, in fact, partially inhibit the subsequent response to IL-12, suggesting that IL-2 production, or another CsA- sensitive signaling pathway, is required for the induction of IL-12 responsiveness. We therefore employed a second approach, in which control or anergic A.E7 cells were activated by Ag/APC in the presence of exogenous IL-2, to determine whether IL-2 reconstitution of anergic cell activation cultures would allow subsequent proliferation to IL-12 at control cell levels. Fig. 3 C demonstrates that the IL-12-mediated proliferation of both anergic and control ceils was enhanced by prior exposure to IL-2, even in the absence of Ag. It is interesting to note that control cell proliferation to IL-12 was also enhanced by exposure to IL-2 during Ag activation, suggesting suboptimal Ag-mediated IL-2 production for this response by control cells, and supporting a role for IL-2 during induction of IL-12 responsiveness. It is difficult to evaluate the IL-2 concentration needed during activation for optimal subsequent IL-12-mediated proliferation, due to IL-2 use during the activation step. Complementary experiments that employed anti-IL-2/IL-2R Ab to block endogenous IL-2 use by control cells were inconclusive because complete inhibition was not achieved (data not shown). However, the data shown in Fig. 3 C indicate that IL-2 reconstitution of anergic cell Ag activation cultures resulted in only a marginal increase in subsequent proliferation to IL-12, and was insufficient to allow IL-12-mediated proliferation at control cell levels. The IL-12 response of anergic cells activated with an optimal Ag concentration plus IL-2 was only 60% of the response found with control cells activated minus IL-2, and was only 20% of the response of control cells activated plus IL-2. These results indicate that defective ILo2 production by anergic cells is not solely responsible for the defect in induction of IL-12 responsiveness. Similar results were found when the anergic cell defect for induction of IL-4 responsiveness was analyzed (8) . (17, 24), anergy was not lost in these experiments, perhaps because cell division was limited after a single exposure to 1112. Anergic cell recoveries from cultures containing Ib2 were increased by twofold over those from cultures without 1112, but we have found that a fivefold increase is needed to demonstrate reversal of anergy (Quill, H., unpublished observations).
Impaired Induction of lL-12-mediated Proliferation Is Observed in Anergic CD4 + T Cells Tolerized In
Mls-1 b mice after injection of Mls-l'-positive spleen cells. These transgenic mice express V/58.1 on >95% of peripheral T cells and become tolerant for TCR-mediated proliferative responses after intravenous exposure to the Mls-1 a superantigen that is recognized by V/38.1 (6) . The persistence of a large number of anergic VBS.1 cells is evident in the periphery of these mice, and these anergic cells are unable to produce IL-2 or to proliferate when stimulated in vitro with Mls-P-positive APC (6, and Table 1 ). In the presence of IL-12, both control and anergic cells showed enhanced proliferation over that seen with Ag alone, but the anergic cell response was considerably lower than that found with control cells (Table 1) . Therefore, anergic CD4 + T cells tolerized in vivo also exhibit impaired IL-12 responsiveness, similar to our findings with Thl clones that are tolerized in vitro.
Effect of lL-12 on the Production of lFN-?" by Anergic Thl Cells. In addition to stimulating T cell proliferation, IL-12
is known to induce IFN-3, production by T cells and to synergize with TCR-mediated stimulation, IL-2 and other stimuli for IFN-3' production (12, 13). As an independent assay for induction of IL-12 responsiveness in anergic Thl clones, we also measured IFN-3, secretion during culture with Ag/APC plus IL-12. In contrast to the nearly complete block in induction of proliferation to Ag/APC, anergic Thl cells can be stimulated to produce [FN-3', but they are less sensitive to Ag for this response (2) . As shown in Fig. 4 Although the clear functional consequence of anergy is decreased Ag-dependent IFN-y production even in the presence of IL-12, it is not yet known why IL-12 cannot rescue the IFN-3, response. Our data suggest the possibility that a primary IL-12-independent defect in Ag-mediated IFN-'y production may explain the decrease in total IFN-y secretion by anergic cells cultured with Ag plus IL-12. As seen in Fig.  4 B, Ag does activate IL-12-dependent IFN-3, secretion in anergic cells, but only to a suboptimal level vs control cells. The difference between control and anergic cells seen in the absence of IL-12 is maintained in the presence of IL-12. Thus, although IL-12 cannot override the anergic cell defect in IFN-7 production, the relative activity of IL-12 is similar with control and anergic cells, suggesting that the limited IFN-7 response induced by Ag can be enhanced normally by IL-12 in anergic cells. It is possible, therefore, that decreased synergy between IL-12 and Ag/APC-mediated signals reflects an impaired contribution by TCR-mediated events, and not an intrinsic defect in the induction of the response to IL-12.
Although other explanations are possible, this interpretation would suggest a dissociation of IL-12 responses in anergic cells, such that IL-12-mediated proliferation is severely blocked, but that the IL-12-mediated enhancement of IFN-3' production can still occur. Dissociation of IL-12 responses might reflect different signaling pathways used for proliferation vs IFN-y production, or might result from heterogeneity in the IL-12R, which has not yet been well characterized (22) .
IL-12 is thought to play a major role in generating and, perhaps, in perpetuating Thl-type responses in vivo (23) , and it is of interest that anergy in both Thl clones and in normal CD4 § T cells includes tolerance for IL-12-mediated proliferation. Once reagents specific for the murine IL-12R are available, it will be important to determine if the defect in anergic cells reflects an inability to express one or more of the putative subunits of the IL-12R (22) , or alternatively, reflects a block in signaling pathways mediated by this receptor. The current results extend our understanding of anergic CD4 + T cells by demonstrating an additional functional defect that may contribute to the maintenance of tolerance for Thl-type responses.
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